Diagnosis and Management of Gynecomastia for Urologists.
Recommended Citation
Baumgarten L, and Dabaja AA. Diagnosis and Management of Gynecomastia for Urologists. Curr Urol Rep 2018; 19(7):46
Document Type
Article
Publication Date
5-17-2018
Publication Title
Current urology reports
Abstract
PURPOSE OF REVIEW: Our aim is to review the steps of diagnosis and management of gynecomastia with a special focus on treatment of gynecomastia associated with androgen deprivation therapy for prostate cancer.
RECENT FINDINGS: Recent studies investigating tamoxifen and radiation therapy for both therapy and prophylaxis of bicalutamide-induced gynecomastia are reviewed. Gynecomastia is a common clinical problem, affecting between one and two thirds of middle-aged men. Diagnosis is typically made by history and physical exam. Common causes include chronic medical conditions and medications; however, unexplained gynecomastia should prompt laboratory work-up, followed by appropriate imaging studies to evaluate for hormone producing cancers. For patients taking bicalutamide for treatment of prostate cancer, tamoxifen or radiation therapy for gynecomastia are excellent options.
Medical Subject Headings
Androgen Antagonists; Anilides; Estrogen Antagonists; Gynecomastia; Humans; Male; Nitriles; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds
PubMed ID
29774423
Volume
19
Issue
7
First Page
46
Last Page
46